Advertisement Pharmaceutical Business review - Page 83 of 5278 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 23, 2026

Lilly and BioArctic sign deal to develop neurodegenerative therapy

Eli Lilly and Company has signed a research and collaboration agreement with Swedish biopharmaceutical company BioArctic to develop a potential treatment for neurodegenerative diseases.